Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer
Condition(s):Metastatic Tumor; Renal Cell Carcinoma; Advanced CancerLast Updated:August 18, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Metastatic Tumor; Renal Cell Carcinoma; Advanced CancerLast Updated:August 18, 2023Recruiting
Condition(s):Kidney CancerLast Updated:November 13, 2023Active, not recruiting
Condition(s):Melanoma Stage III; Melanoma Stage IV; Ovarian Cancer; Renal Cancer Stage III; Renal Cancer Stage IV; Lung Cancer, Non-small CellLast Updated:February 28, 2022Completed
Condition(s):Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Carcinoma; Stage IV Renal Cell Cancer; Type 1 Papillary Renal Cell Carcinoma; Type 2 Papillary Renal Cell CarcinomaLast Updated:August 28, 2018Completed
Condition(s):Kidney CancerLast Updated:March 20, 2013Completed
Condition(s):Carcinoma, Renal CellLast Updated:October 19, 2020Completed
Condition(s):Carcinoma, Renal CellLast Updated:March 3, 2020Completed
Condition(s):Renal Cell CarcinomaLast Updated:January 12, 2017Terminated
Condition(s):Renal Cell CarcinomaLast Updated:August 18, 2014Completed
Condition(s):Advanced Clear Cell Renal Cell Carcinoma; Metastatic Clear Cell Renal Cell Carcinoma; Stage III Renal Cell Cancer AJCC v8; Stage IV Renal Cell Cancer AJCC v8Last Updated:February 20, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.